Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinase
Masami Kondo(University of Shizuoka), Naoto Oku(University of Shizuoka), Yasufumi Katanasaka(University of Shizuoka), Hideo Tsukada(Hamamatsu Photonics (Japan)), Kōichi Ogino(Otsuka (Japan)), Yasuyuki Sadzuka(Iwate Medical University), Tomohiro Asai(University of Shizuoka), Kazuhiko Baba(Taiho Pharmaceutical (Japan)), Takao Taki(University of Shizuoka)
Cited by 78
Related Papers
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673
Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody
|Journal of the American Chemical Society|2010|486
Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells
|Cell Communication & Adhesion|1994|417
Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
|Journal of Biological Chemistry|1993|256
The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo
|Proceedings of the National Academy of Sciences|2011|202